Hone Health vs. Marek Health
Advertising Disclosure: TelehealthIndex is reader-supported. If you sign up with a
provider through links on this page, we may earn a commission at no extra cost to you.
Commissions never influence our scores or rankings — several of our top-rated providers pay
us nothing. How we score → · Full disclosure →
46.8/100Not Recommended
Marek Health
Not Recommended · #9 in Men's Health (ED & TRT)
Visit Marek Health Read full review Our read: Under our 100-point methodology, Hone Health scores 53.7/100 and Marek Health scores 46.8/100 — so Hone Health ranks higher in our assessment. Scores are editorial opinions, not a factual ranking of the companies themselves; the right fit depends on how you pay and what you need — see the breakdown below.
| Factor | Hone Health | Marek Health |
|---|---|---|
| Clinical credibility | Weak | Weak |
| Regulatory & safety record | Minor deductions | Notable deductions |
| Transparency & trust | Mixed | Weak |
| Access & coverage | Weak | Weak |
| Customer experience | Strong | Exceptional |
| Value & pricing | Weak | Weak |
Factor ratings are qualitative summaries of our internal rubric — we do not publish the
point weights. Highlighted = the higher-rated provider on that factor.
TelehealthIndex scores and rankings are editorial opinions resulting from our selection, weighting, and interpretation of the factors described in our methodology.
Choose Hone Health if…
- you want the higher overall score on our methodology
Choose Marek Health if…
- you need the widest state coverage
- a stronger consumer-review record matters to you
| Hone Health | Marek Health | |
|---|---|---|
| Pricing | $65 initial labs+consult; $25/mo membership + meds (T from $28/mo) | ~$3,500-7,250/yr all-in (labs $450-1,700; coaching $250-400/mo) |
| Insurance | No | No |
| Availability | Not disclosed | 45 states |
| Money-back | Not advertised | Not advertised |
| Founded | 2020 | 2021 |
Note: one or both providers offer compounded medications for some services.
Compounded medications are not FDA-approved.
Data as of July 19, 2026. Scores are editorial opinions reflecting documented business practices, transparency, pricing, access, and nonclinical consumer-service factors — not clinical quality or outcomes. Found an error? Report it →